A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.

Blood
Guillem ClotElias Campo

Abstract

Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy, but some patients have a very indolent evolution. This heterogeneous course is related, in part, to the different biological characteristics of conventional MCL (cMCL) and the distinct subgroup of leukemic nonnodal MCL (nnMCL). Robust criteria to distinguish these MCL subtypes and additional biological parameters that influence their evolution are not well defined. We describe a novel molecular assay that reliably distinguishes cMCL and nnMCL using blood samples. We trained a 16-gene assay (L-MCL16 assay) on the NanoString platform using 19 purified leukemic samples. The locked assay was applied to an independent cohort of 70 MCL patients with leukemic presentation. The assay assigned 37% of cases to nnMCL and 56% to cMCL. nnMCL and cMCL differed in nodal presentation, lactate dehydrogenase, immunoglobulin heavy chain gene mutational status, management options, genomic complexity, and CDKN2A/ATM deletions, but the proportion with 17p/TP53 aberrations was similar in both subgroups. Sequential samples showed that assay prediction was stable over time. nnMCL had a better overall survival (OS) than cMCL (3-year OS 92% vs 69%; P = .006) from the time of diagnosis and lon...Continue Reading

References

Aug 1, 1996·Controlled Clinical Trials·M Schemper, T L Smith
May 2, 2006·Statistical Applications in Genetics and Molecular Biology·Gordon K Smyth
May 5, 2007·Cancer·Ana FerrerEmili Montserrat
Feb 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter MartinJohn P Leonard
Aug 12, 2009·Journal of Hematopathology·Wolfram KlapperUNKNOWN European MCL Network
Oct 7, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heather E EveSimon A J Rule
Jan 26, 2010·Biostatistics·Matthew N McCallRafael A Irizarry
Feb 4, 2010·Cancer Research·Verònica FernàndezElías Campo
Nov 23, 2010·Biostatistics·Kyung In Kim, Richard Simon
Jul 2, 2011·Leukemia·A M HalldórsdóttirR Rosenquist
Jul 26, 2011·Seminars in Hematology·Peter Martin, John Leonard
Oct 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sílvia BeàElías Campo
Dec 20, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Blanca EspinetSergio Serrano
Dec 17, 2014·Blood·Elias Campo, Simon Rule
May 30, 2015·Blood·Marie-Hélène Delfau-LarueUNKNOWN European Mantle Cell Lymphoma Network
Jun 3, 2015·Haematologica·Martin DreylingUNKNOWN European Mantle Cell Lymphoma Network
Mar 2, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eva HosterWolfram Klapper
Nov 16, 2016·Cancer Cell·Ana C QueirósJosé I Martín-Subero
Mar 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David W ScottUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
May 10, 2017·Expert Review of Anticancer Therapy·David Tucker, Simon Rule
Sep 30, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P AbrisquetaD Villa
Oct 7, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Zhihong HuSa A Wang

❮ Previous
Next ❯

Citations

Aug 11, 2018·British Journal of Haematology·Hilka Rauert-WunderlichAndreas Rosenwald
Feb 16, 2019·The American Journal of Surgical Pathology·Jie XuShaoying Li
Jun 13, 2019·Hematological Oncology·Simon Rule
Apr 24, 2020·Expert Opinion on Investigational Drugs·Clémentine Sarkozy, Vincent Ribrag
Jul 28, 2018·Blood·Peter Martin
Aug 1, 2020·The Cancer Journal·Simon Rule, Sophie Johns
Jun 8, 2019·Histopathology·Georgios PetrakisElias Campo
Jul 18, 2020·Current Opinion in Oncology·Pierre Heimann, Laurent Dewispelaere
Apr 28, 2020·Leukemia & Lymphoma·Jia RuanPeter Martin
Apr 10, 2019·American Journal of Hematology·Preetesh Jain, Michael Wang
Jan 25, 2020·Virchows Archiv : an International Journal of Pathology·Giorgio A CrociWolfram Klapper
Jun 19, 2019·Therapeutic Advances in Medical Oncology·Zhi YangZhenxiao Jin
Jun 20, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aline TalhoukMichael S Anglesio
Oct 14, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Santiago DemajoPedro Jares
Nov 17, 2020·Journal of Hematopathology·Colleen A RamsowerLisa M Rimsza
Feb 15, 2021·Methods : a Companion to Methods in Enzymology·Lasse Sommer Kristensen
Aug 31, 2020·Hematology/oncology Clinics of North America·Alba NavarroElías Campo
Aug 31, 2020·Hematology/oncology Clinics of North America·Kevin WangSelina Chen-Kiang
Aug 31, 2020·Hematology/oncology Clinics of North America·Christina Lee, Peter Martin
Aug 31, 2020·Hematology/oncology Clinics of North America·Thomas D Rodgers, Jonathan W Friedberg
Mar 31, 2021·British Journal of Haematology·Elisabeth SilkenstedtMartin Dreyling
May 14, 2020·Cold Spring Harbor Perspectives in Medicine·Laura Pasqualucci, Ulf Klein
Jul 17, 2021·Current Oncology Reports·Krista M IsaacMichael E Williams
Jul 15, 2021·Experimental Hematology & Oncology·Panruo JiangHaige Ye
Jan 15, 2022·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eva GinéArmando López-Guillermo
Dec 8, 2021·Journal of Internal Medicine·Marco M BühlerRichard Rosenquist

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.